Use of Alginate Polymer Polysaccharide Hemostatic Hydrogel in the Treatment of Simulated Bleeding Stomach Defects

The aim of the study was to develop in vivo technique and study the potential of alginate polymer polysaccharide hemostatic hydrogel application in the treatment of experimental bleeding stomach ulcers.
Materials and methods. The in vivo experiment was conducted in the Laboratory of Experimental Surgery, the Research Institute of Experimental Biology and Medicine, N.N. Burdenko Voronezh State Medical University. Twelve healthy laboratory animals (dog) weighed 7-10.5 kg were selected for the study. Each animal was exposed to two bleeding stomach defects: one of which was experimental, and the other was control. Bleeding arrest in the experimental group of animals was carried out by insufflation of powdered alginate polymer polysaccharide hemostatic for a bleeding defect (Patent RF №2762120). Control stomach defects were not subjected to endoscopic treatment. The results of the experimental study were evaluated according to the following parameters: the time of experimental bleeding arrest, the presence of repeated bleeding, the timing and quality of healing simulated defects.
Results. Experimental studies have demonstrated that the alginate polymer polysaccharide hemostatic hydrogel applied in the endoscopic treatment of simulated bleeding stomach defects can significantly (P=0.000001) reduce the time of experimental bleeding, from 26.5(25.3-32.0) sec to 6.0(4.0-8.0) sec, and helps to reduce the regeneration time of experimental defects from 14.5(13.5-16.5) days up to 8.0(7.5-8.5) days (P=0.000001), while improving the quality of their healing.
Conclusion. Thus, the use of alginate polymer polysaccharide hemostatic hydrogel is an effective method of treating simulated bleeding stomach defects.